Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J.
Leukosite, Inc., Cambridge, MA, United States
Search 4 grants from Michael Briskin
Search grants from Leukosite, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Group Antenatal Care: Effectiveness for Maternal/Infant and HIV Prevention Outcomes and Contextual Factors Linked to Implementation Success in Malawi
Autonomic Control of Urinary Function in Diabetic Mice
4D and 5D image reconstruction for cardiac SPECT
Dietary Soy Supplements: Cardioprotective Mechanisms
Exercise and Type II Diabetes - Adherence and Cvd Risk
Recently added grants:
Development of a Synergistic Drug Combination for Prevention and Treatment of Malaria
Degrading therapeutically important kinases using small molecules
Role of proteasome activity in adaptive immunity
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
Arsenic and immune response to influenza vaccination in pregnant women and newborns
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049883-02
Application #
2016997
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1995-06-15
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Leukosite, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1997
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
NIH 1996
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
Comments
Be the first to comment on Michael Briskin's grant